Mesenchymal stem cell regeneration of degenerated intervertebral discs:current status

Yanqiang Wang,Guangwu Zhang
DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2014.01.034
2014-01-01
Abstract:Low back pain, strongly associated with intervertebral disc (IVD) degeneration, affects a large proportion of the population and has major social and economic costs. Current first-line therapies for IVD degeneration such as physical therapy and spinal fusion address symptoms, but do not treat the underlying degeneration. As such, efforts are being directed towards development of therapies aimed at alleviating pain through the restoration of the IVD function. The use of tissue engineering to treat IVD degeneration provides an opportunity to correct the pathological process. Adult mesenchymal stem cells (MSCs), capable of differentiating down the discogenic lineage, have shown promise as a suitable cell source for IVD tissue engineering. However, the use of MSCs for IVD degeneration is still at the stage of preclinical and Phase 1 studies, a number of factors remain to be addressed, including understanding whether and how the MSCs survive and thrive in the hostile microenvironment of the degenerated IVD, identification of suitable biomaterials for cell implantation, and ensuring the safety of MSCs implantation.
What problem does this paper attempt to address?